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The activity of smooth and non-muscle myosin II is regulated by phosphoryla-
tion of the regulatory light chain (RLC) at ser19. The dephosphorylated state
of full-length monomeric myosin is characterized by an asymmetric intramo-
lecular head-head interaction that completely inhibits the ATPase activity,
accompanied by a hairpin fold of the tail, which prevents filament assembly.
The mechanism by which ser19 phosphorylation disrupts these head-head
interactions is unknown. Computational modeling (Tama et al., 2005. J. Mol.
Biol. 345, 837-854) suggested that formation of the inhibited state is character-
ized by both torsional and bending motions about the myosin heavy chain (HC)
at a location between the RLC and the essential light chain (ELC). Based on
this model, placement of the regulatory domain at this locus might alter relative
motions between the ELC and the RLC and thereby disrupt the inhibited state.
Here we derive an atomic model based on this hypothesis for the phosphory-
lated state of the smooth muscle myosin light chain domain (LCD). We use
a homology model for the structure of the RLC and a largely a-helical structure
for the regulatory domain. This model predicts a set of specific interactions
between the regulatory domain and both the myosin HC and the ELC. Site
directed mutagenesis combined with ATPase and motility assays was used to
show that interactions between the highly basic N-terminus of the RLC with
acidic residues on helix-A of the ELC are required for phosphorylation to acti-
vate smooth muscle myosin. These sites are well conserved in all the myosin II
ELC sequences examined despite the lack of known interacting partners and
when substituted, are usually substituted with aspartic acid. Supported by
NIH grants AR47421, AR53975 and HL38113 and RR12255.
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The A1 light chain of rabbit skeletal myosin possesses a unique N-terminal
extension of ~40 amino acids which is lacking in A2. A C-terminal block of
~140 amino acids is identical to both. The primary structures are completed
by a small, non-identical peptide which is sandwiched between the above
two sections of A1 and which is N-terminal in A2. The effect which A1 and
A2 have on the product release step has been investigated by double-mixing
stopped-flow in conjunction with a fluorescent phosphate binding protein
(Buffer, 5mM MOPS, 2mM Mg acetate, pH 7). Rabbit skeletal myosin-S1
was chromatographically separated into A1 and A2 containing fractions. A
slight excess of myosin-S1 over nucleotide was used in the first mix to ensure
complete binding of the latter as well as a single turnover. After a 2 s delay to
assure that ATP binding was complete, thin filaments (þCa) were combined
with the myosin-nucleotide mixture (M-ATP Uˆ M-ADP-Pi) in the second
mix. The dominant component of the observed biphasic increase in fluores-
cence corresponds to Pi release from AM-ADP-Pi. Hyperbolic fits of the depen-
dence of the rate upon the thin filament give maximum rates of: 80 s-1 (S1A1)
and 139 s-1 (S1A2) and apparent binding constants of 10 mM (S1A1) and 72
mM (S1A2). The rates of phosphate dissociation are 4-5 more rapid than the
steady state measurements of 20 s-1 (A1) and 36 s-1 (A2) and therefore cannot
limit the rate of ATP hydrolysis. It is also evident that the N-terminal extension
strengthens light chain affinity.
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The R21C mutation in cTnI, associated with hypertrophic cardiomyopathy
(HCM), is the only known mutation within N-terminus of cTnI. The mecha-
nisms by which this mutation leads to heart failure, and how this mutationaffects PKA regulation of cTn function and myofibril relaxation still remain
elusive. Currently, we are studying this mutation using an integrated
experimental-computational approach. We generated triple-mutated cTnI
(cTnI-R21C/S2324D) to mimic the phosphorylation. From steady-state fluores-
cence measurement, which using a fluorescent probe (IANBD) coupled to
cTnCC35S, C-I binding affinity (KC-I) and calcium binding affinity (KCa) to
whole cTn were monitored. cTnIR21C increased both KC-I and KCa compared
to cTnIWT. Phosphorylation of cTnI reduced KCa for both complexes. However,
while PKA treatment weakened KC-I for cTnI
WT, this effect was not absent in
cTnIR21C. To study myofibril contraction/relaxation mechanics and kinetics,
endogenous cTn was exchanged with either WT or R21C recombinant cTn,
and mechanics were monitored at maximum and submaximal Ca2þ conditions.
The kinetics of activation (KACT) is slower at submaximal vs maximal Ca
2þ
conditions, and not affected by PKA treatment of myofibrils containing either
cTnIWT or cTnIR21C. However, PKA treatment of cTn with cTnIWT signifi-
cantly affected slow phase relaxation, increasing slow phase rate (KREL,slow)
and decreasing slow phase duration (tREL, slow), and these effects are more clear
at submaximal calcium levels. Interestingly, these PKA mediated effects
were blunted in cTnIR21C. Molecular dynamics (MD) simulations of whole
cTn with R21C and R21C/S23DS24D substitution are ongoing. Interactions
between cNTnC-cNTnI, cNTnC-switch peptide of cTnI, and cTnC-inhibitory
peptide of cTnI will be monitored, and calcium binding sites will be studied.
Computational results will provide the structural basis at molecular level
of how R21C influence C-I binding and relaxation of cardiac muscles.
HL65497, HL11197 (MR), 8P41GM103426 (AM & AM).
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Detachment-limited models of muscle shortening assume that with increasing
myosin densities maximal velocities are achieved when at least one myosin
head is bound to a given actin filament. However, numerous studies suggest
that actin sliding velocities, V, are influenced by actin-myosin attachment
kinetics, suggesting that V should saturate - along with actin-activated myosin
ATPase activity, v - when myosin heads saturate binding sites on actin. Here we
used an in vitro motility assay to measure both V and v in the same flow cell.
We observed that both V and v exhibited similar saturation kinetics with
increasing myosin densities and that increasing ionic strength similarly
decreased the Km for both activation curves. Using the same in vitro assay,
we measured the calcium-dependence of V for regulated thin filaments (actin
filaments reconstituted with tropomyosin and troponin) and observed that
the myosin-dependence of calcium sensitivity (pCa50) exhibited saturation
kinetics similar to that of V and v. These results suggest that saturation of
V, v, and pCa50 all occur when myosin saturates binding sites on actin. This
is consistent with estimates showing that saturating myosin densities in a
motility assay correspond to a linear spacing of myosin along an actin filament
that is similar to the repeat of myosin binding sites along one side of the
filament.
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HCM and DCM-causing mutations alter myofilament Ca2þ-sensitivity but
many also uncouple the phosphorylation of Ser 22 and 23 of cardiac troponin
I from the change in Ca2þ-sensitivity.
We studied the effects of small molecules that also modulate Ca2þ-sensitivity
using single thin filaments containing human cardiac troponin in the in vitro
motility assay.
EMD57033 is a Ca2þ-sensitiser and causes a dose dependent increase in Ca2þ-
sensitivity (optimum at 30mM). The increase in Ca2þ-sensitivity was 2-fold for
fraction motile and 5-fold for motile velocity. EMD57033 increased Ca2þ-
sensitivity in wild-type, in DCM mutations (TPM1 E40K and E54K) and in
troponin from myectomy samples. In addition, in wild-type, Ca2þ-sensitivity
becomes independent of troponin I phosphorylation, this uncoupling resembles
the effect of HCM mutations.
Epigallocatechin 3-Gallate (EGCG) is a Ca2þ-desensitiser, 100mM reduces
Ca2þ-sensitivity of native human thin filaments by 1.5-fold. The maximum
sliding speed was reduced as well. EGCG also decreased Ca2þ-sensitivity in
thin filaments with DCM mutations (TPM1 E40K and E54K, 1.3- and 3.5-
fold respectively) and in troponin from myectomy samples (1.6-fold).
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tivity to thin filaments containing tropomyosin DCM mutations or myectomy
samples where the Ca2þ-sensitivity is normally uncoupled.
Thus, for thin filaments with TPM1 E40K mutation, Ca2þ-sensitivity of phos-
phorylated and unphosphorylated troponin is the same (EC50 0.261mM and
0.252mM respectively) whilst in the presence of EGCG, Ca2þ-sensitivity
dependence on phosphorylation is restored (EC50 P=0.324mM, unP =
0.104mM). The same pattern was observed with TPM1 E54K containing thin
filaments and also in troponin from myectomy samples that are usually
uncoupled (EC50 P = 0.139mM, unP = 0.137mM in absence but P =
0.231mM, unP = 0.183mM in presence of EGCG.
Thus, EGCG potentially can reverse the effect of mutations that cause DCM.
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Numerous neurological diseases lead to paralysis of intact skeletal muscles.
Electrical stimulation of these to restore contraction is problematic due to
side effects, the lack of cellspecificity and simultaneous activation of antagonist
muscles.
Optogenetic stimulation of skeletalmuscles expressing the light-sensitive cation
channel Channelrhodopsin2 (ChR2) could overcome these limitations. There-
fore we have generated a transgenic mouse line with expression of ChR2 fused
to EYFP in skeletal muscles under the control of the chicken-b-actin promotor.
Soleus muscles showed membrane bound EYFP fluorescence and light induced
force was analyzed by isometric force measurements upon illumination
(470nm) with different durations, intensities and repetition rates. Using single
light pulses, the highest force generation (52.753.4mN, sd, n=4) was reached
by 100ms long pulses with a light intensity of 0.51mW/mm2. For tetanus
stimulation we found that 5ms pulses at 30Hz and 1.4mW/mm2 were most
efficient and led to the force of 69.157.7mN (sd,n=4). This was ~70% of the
force generated by electrical tetanus stimulation.
Bilateral laryngeal paralysis is a severe disease resulting in immobility of the
vocal cords and life-threatening dyspnea. In this disease electrical stimulation
is problematic due to electrode corrosion, recognition of the stimuli and non-
selective stimulation of agonist and antagonist muscles (Zealer DL et al.,
Laryngoscope 2003,113:1149-1156). We therefore tested the feasibility of
selective optogenetic stimulation of the posterior cricoarytenoid muscle, which
is the only intralaryngeal muscle opening the vocal cords. Larynges were iso-
lated from ChR2-transgenic mice and locally stimulated with a light guide
(Ø400mm,NA=0,48) in the postarytenoid region. Application of light pulses
(470nm,50ms,35.7mW/mm2) led to a repetitive opening of the vocal cords.
The distance between vocal cords during illumination was 230538% of
baseline (sd,n=3).
Thus optogenetic muscle stimulation is a promising method for therapy of
nerve lesions and might be useful to treat bilaryngeal paralysis.
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Oxidative stress is a critical disease modifier in the muscular dystrophies.
Recently we discovered X-ROS, a pathway by which mechanical stretch acti-
vates NADPH Oxidase 2 (NoX2) dependent ROS generation (Prosser et al,
2011). Our work in dystrophic skeletal muscle (Khairallah et al, 2012) revealed
X-ROS is excessive in dystrophin deficient (mdx) skeletal muscle where it con-
tributes muscle injury susceptibility, a hallmark of the dystrophic process. Our
transcriptional interrogation of the X-ROS pathway in human DMD and in mdx
revealed a widespread alteration in genes associated with redox homeostasis.
As Nrf2 plays an essential role in the transcriptional regulation of genes
involved in redox homeostasis we hypothesized that reductions in Nrf2 activity
may contribute to the enhanced X-ROS signaling by reducing redox buffering.
In our first experiment, we treated adult (6 month) mdx mice with sulforaphane,an activator of Nrf2 which transcriptionally up regulates antioxidant enzyme
expression thus increasing the ability of cells to scavenge ROS. Following
5 days of treatment the sentinel antioxidant enzyme, glutathione reductase,
was significantly increased in the muscle. Furthermore, X-ROS was signifi-
cantly abrogated in treated vs. untreated animals. To directly test the effect
of decreased Nrf2 activity, Nrf2 was genetically silenced in the A/J model of
dysferlinopathy; a model is notorious for having a mild functional phenotype,
which has raised doubts about its relevance for dysferlinopathy. With Nrf2
silencing, 1 year old A/J mice had significant muscle specific functional deficits
and altered histopathology compared to non-silenced controls and X-ROS was
dramatically enhanced. We propose that strategies targeting Nrf2 activation
will address generalized reduction in redox homeostasis, which is a core mech-
anism of dystrophic progression.
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We recently identified the microtubule (MT) cytoskeleton (Khairallah et al,
2012) as the critical mechano-transduction element for stretch activated
NADPH Oxidase 2 (NoX2) dependent ROS generation (i.e., X-ROS; Prosser
et al, 2011) which activates mechano-sensitive Ca2þ influx. In WT skeletal
muscle, X-ROS was minimal to undetectable with acute mechanical stretch
but dramatically amplified by increasing MT density. In dystrophic myofibers
(mdx), elevated X-ROS was coincident with increased MT density and amelio-
rated by depolymerizing MT (Khairallah et al, 2012, Prosser et al, 2013). Our
data support the hypothesis that MT density tunes X-ROS activity and Ca2þ
influx. These novel insights were possible because of our use of brief, acute
stretch in single, enzymatically isolated skeletal myofibers - a model where
baseline ROS generation and cytosolic [Ca2þ] is low, allowing the identifica-
tion of stretch-induced X-ROS and its subsequent Ca2þ influx. In vivo studies
targeted MT density in mdx and blunted contraction-induced injury. We now
report a similar effect in WT mice, indicating that contraction-activated
X-ROS is operant in WT. However, our initial single cell approach could not
support electrically-elicited contraction, leading us to develop novel technol-
ogy and methodology that allows the reliable measurement of dynamic stretch
and isometric contractility. We find that X-ROS and Ca2þ influx in WT are
modulated by the frequency of passive stretch and electrically-elicited contrac-
tion. We are extending these studies with new genetic models and pharmaco-
logic and molecular approaches that alter MT density to evaluate its
contribution to mechano-activation of X-ROS and Ca2þ during dynamic stretch
or contraction. We also show the contribution of MT density to the mechanical
properties of the myofiber with measures of near-membrane stiffness by axial
deformation (AFM) and passive stiffness during longitudinal stretch.
Work funded by R01-AR062554, R01-HL106056.
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Duchenne muscular dystrophy (DMD) is a common genetic disorder character-
ized by chronic inflammation and severe muscle wasting caused by the absence
of dystrophin. In mdx muscle fibers, we have shown that basal ATP release was
increased and that extracellular ATP stimulation is pro-apoptotic. In normal
fibers, ATP release is blockedby nifedipine leading us to study the potential ther-
apeutic effect of nifedipine in mdx mice and its relation with extracellular ATP
signaling. Six-week-old mdx mice were treated with daily intraperitoneal injec-
tions of nifedipine, 1mg/Kg for 1-week. This treatment significantly reduced
extracellular ATP levels in adult mdx flexor digitorum brevis (FDB) fibers
and lowered the intracellular resting Ca2þ concentration ([Ca2þ]r) measured
in vivo in the vastus lateralis. Acute treatment of mdx FDB fibers with apyrase,
reduced [Ca2þ]r to a similar extent as was seen in vastus lateralis after nifedipine
treatment. Physiologically, nifedipine treatment increased muscle strength as-
sessed by both the inverted grip-hanging test and forced swimming test, and
decreased serum CK in mdx mice. Exploring mechanisms, nifedipine treatment
reduced mRNA levels of iNOS, gp91phox, p47phox and Bax in mdx diaphragm
